Menu
Search
|

Menu

Close
X

Laboratory Corporation of America Holdings LH.N (New York Stock Exchange)

174.41 USD
-- (--)
As of Feb 20
chart
Previous Close 174.41
Open --
Volume --
3m Avg Volume 169,048
Today’s High --
Today’s Low --
52 Week High 181.65
52 Week Low 134.49
Shares Outstanding (mil) 102.43
Market Capitalization (mil) 17,864.81
Forward P/E 24.18
Dividend (Yield %) -- ( -- )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
2.05 Mean rating from 20 analysts

KEY STATS

Revenue (mm, USD)
FY17
10,441
FY16
9,642
FY15
8,680
EPS (USD)
FY17
7.214
FY16
7.016
FY15
4.261
*Note: Units in Millions of U.S. Dollars
**Note: Units in U.S. Dollars

KEY RATIOS

Price to Earnings (TTM)
vs sector
24.18
35.64
Price to Sales (TTM)
vs sector
1.71
8.67
Price to Book (MRQ)
vs sector
2.61
5.21
Price to Cash Flow (TTM)
vs sector
13.87
26.03
Total Debt to Equity (MRQ)
vs sector
99.01
15.38
LT Debt to Equity (MRQ)
vs sector
92.89
12.01
Return on Investment (TTM)
vs sector
5.61
13.57
Return on Equity (TTM)
vs sector
12.15
15.19

EXECUTIVE LEADERSHIP

David King
Chairman of the Board, President, Chief Executive Officer, Since 2009
Salary: $1,133,330.00
Bonus: $1,785,420.00
Glenn Eisenberg
Chief Financial Officer, Executive Vice President, Since 2014
Salary: $653,438.00
Bonus: $679,626.00
John Ratliff
Chief Executive Officer - Covance Drug Development, Since
Salary: --
Bonus: --
Lisa Uthgenannt
Chief Human Resource Officer, Since 2015
Salary: $440,171.00
Bonus: $318,912.00
Edward Dodson
Senior Vice President, Chief Accounting Officer, Principal Accounting Officer, Since 2014
Salary: --
Bonus: --

COMPANY PROFILE

Sector: Healthcare
Industry: Healthcare Facilities & Services
Address:

358 S MAIN ST
BURLINGTON   NC   27215-5837

Phone: +1336.2291127

Laboratory Corporation of America Holdings is a life sciences company that is integrated in guiding patient care, providing clinical laboratory and end-to-end drug development services. The Company operates as a healthcare diagnostics company. The Company operates through two segments: LabCorp Diagnostics (LCD) and Covance Drug Development (CDD). The LCD segment is an independent clinical laboratory business, which offers menu of frequently requested and specialty testing through an integrated network of primary and specialty laboratories across the United States. The CDD segment offers drug development services, and provides a range of drug research and development (R&D) and market access services to biopharmaceutical companies and medical device companies across the world. It serves a range of customers, including managed care organizations (MCOs), biopharmaceutical companies, governmental agencies, physicians and other healthcare providers.

SPONSORED STORIES